Prevest Denpro is currently trading at Rs. 425.50, up by 6.80 points or 1.62% from its previous closing of Rs. 418.70 on the BSE.
The scrip opened at Rs. 420.00 and has touched a high and low of Rs. 425.50 and Rs. 420.00 respectively. So far 3200 shares were traded on the counter.
The BSE group 'M' stock of face value Rs. 10 has touched a 52 week high of Rs. 494.50 on 09-Sep-2022 and a 52 week low of Rs. 260.95 on 14-Mar-2023.
Last one week high and low of the scrip stood at Rs. 434.35 and Rs. 399.00 respectively. The current market cap of the company is Rs. 510.73 crore.
The promoters holding in the company stood at 73.60%, while Institutions and Non-Institutions held 1.25% and 25.14% respectively.
Prevest Denpro has incorporated a wholly owned subsidiary company namely Denvisio Biomed. The objective of incorporation is to carry on the business of Sales, Marketing, business is outside the main line of business distribution, trading, and manufacturing and providing Consultancy of and for Dental, Medical, Surgical Devices, Instruments and Equipments, Dental materials etc.
Another objective is to import, Export and to act as consignor, consignee, or agent to sell Dental, Medical, Surgical Devices, Instruments and Equipment’s, Dental materials etc. for self or others on principal-to principal basis or otherwise.
Prevest Denpro manufactures and markets a range of dental materials for diagnosing, treating, and preventing dental conditions and improving the aesthetics of the human smile.
| Company Name | CMP |
|---|---|
| Lenskart Solutions | 540.90 |
| Poly Medicure | 1480.80 |
| Laxmi Denta | 198.45 |
| Nureca Ltd. | 260.25 |
| Hemant Surgical Inds | 300.45 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: